UnknownNot Applicable

ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming Individuals

Canada60 participantsStarted 2024-03-01

Plain-language summary

This study aims to assess the feasibility, acceptability and preliminary effectiveness of Acceptance Commitment Therapy, in conjunction with motivation enhancement, and the use of the ChillTime App, in reducing methamphetamine use in women with MUD with or without co-occurring psychiatric disorders. This intervention is designed to be delivered remotely (e.g., participants can complete the entire study from home), with the option for in person attendance if it is not feasible or safe for participants to attend from home.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Meet SCID DSM-5 criteria for Methamphetamine Use Disorder * Over the age of 18 * Female, woman, or non-binary and comfortable participating in women's group * Capacity to provide informed consent * Adequate English language abilities Exclusion Criteria: * Experiencing acute or unmedicated psychosis that would reasonably prevent them from engaging in and/or benefiting from the intervention * Experiencing acute and severe suicidal ideation such that institutionalization and supervised care is warranted * Experiencing severe cognitive deficits that would reasonably prevent them from consenting, engaging in, and/or benefiting from the intervention

What they're measuring

Feasibility of intervention

Timeframe: Immediately after intervention

Acceptability of intervention

Timeframe: 1 month follow-up

Trial details

NCT IDNCT05334914

SponsorCentre for Addiction and Mental Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-31

Contact for this trial

Pamela Sabioni, PhD

4165358501 ACTforMUD@camh.ca; pamela.sabioni@camh.ca